Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer
Clinical trial NCT02772107 · UNKNOWN
Trial details
- NCT number
- NCT02772107
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-06-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.